This inventor holds 1 USPTO granted patent. Top assignee: The University of Queensland. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations of Junxian Lim in Pharmaceutical Research
Introduction
Junxian Lim is a notable inventor based in Indooroopilly, Australia. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for therapeutic applications. His work focuses on addressing critical health issues such as metabolic syndrome, obesity, type II diabetes, fibrosis, and cardiovascular diseases.
Latest Patents
Junxian Lim holds 1 patent for his invention titled "Modulators of protease activated receptors." This patent presents novel compounds that can be utilized as tools for biological studies or as agents for therapies. The pharmaceutical compositions derived from these compounds have the potential to be used alone or in combination with other treatment modalities, enhancing their effectiveness in treating various health conditions.
Career Highlights
Lim is affiliated with The University of Queensland, where he engages in cutting-edge research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions. His contributions have been recognized within the academic community, underscoring his role as a leading figure in pharmaceutical innovation.
Collaborations
Throughout his career, Junxian Lim has collaborated with esteemed colleagues, including David P Fairlie and Ligong Liu. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research endeavors.
Conclusion
Junxian Lim's innovative work in pharmaceutical research exemplifies the potential of scientific inquiry to address pressing health challenges. His contributions continue to pave the way for advancements in therapeutic strategies, ultimately benefiting society as a whole.